Trials / Completed
CompletedNCT07000565
The Effect of Eye Care With Artificial Tears and Normal Saline on Ocular Surface Disease in Mechanically Ventilated Pediatric Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Marmara University · Academic / Other
- Sex
- All
- Age
- 28 Days – 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this study is to comparatively examine the effects of eye care practices using artificial tears and normal saline on superficial ocular injuries in pediatric patients receiving mechanical ventilation in the intensive care unit. Based on the findings, the study seeks to provide evidence-based contributions to nursing practices. Additionally, it aims to identify educational strategies to enhance intensive care nurses' knowledge and practice levels and to support the development of clinical care protocols. H0: There is no difference in the effect of eye care with normal saline and artificial tears on superficial ocular injury in mechanically ventilated pediatric patients. H1:Eye care with normal saline is more effective than artificial tears in preventing superficial ocular injury in mechanically ventilated pediatric patients. H2: Eye care with artificial tears is more effective than normal saline in preventing superficial ocular injury in mechanically ventilated pediatric patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Eye Care with Artificial Tears | Every 2 hours, the artificial tear solution was gently applied to the designated eye for 5 days. The artificial tear product (REFRESH®) contains 5.6 mg of polyvinyl alcohol and 2.4 mg of povidone per mL and is used to maintain ocular surface moisture and reduce irritation. |
| OTHER | Eye Care with Normal Saline | Every 2 hours, the saline solution(Bio-Fleks brand) was gently applied to the designated eye for 5 days. |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-01-01
- Completion
- 2025-01-01
- First posted
- 2025-06-03
- Last updated
- 2025-06-03
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07000565. Inclusion in this directory is not an endorsement.